» Articles » PMID: 8983610

Recurrence of Hepatocellular Carcinoma After Surgery

Overview
Journal Br J Surg
Specialty General Surgery
Date 1996 Sep 1
PMID 8983610
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

A total of 386 patients who underwent complete resection of hepatocellular carcinoma over an 8-year period were assessed retrospectively for tumour recurrence. Some 219 (56.7 per cent) of the patients developed recurrence. Patients with a greater degree of cirrhosis showed a longer interval to recurrence; the median (range) interval until recurrence was 7.9 (1.8-84.2) months in patients with a normal liver, 13.4 (2.0-79.5) months in those with chronic hepatitis and 16.7 (1.5-73.1) months in those with cirrhosis. Intrahepatic recurrence was observed more frequently in either the same (26.4 per cent) or the adjacent (24.8 per cent) Healey segment than in the lobe contralateral to the primary tumour (17.8 per cent). The presence of portal venous invasion and/or intrahepatic metastasis, underlying liver cirrhosis and perioperative blood transfusion were determined to be independent predictors of recurrence by multivariate analysis. Because intrahepatic spread of hepatocellular carcinoma occurs in a segment-by-segment manner, surgeons should use an anatomically wide resection within the hepatic functional reserve.

Citing Articles

Identification and validation of a prognostic model based on four genes related to satellite nodules in hepatocellular carcinoma.

Liu F, Yan T, Cui D, Jiang J Sci Rep. 2024; 14(1):15633.

PMID: 38972883 PMC: 11228042. DOI: 10.1038/s41598-024-66610-z.


Impact of anatomical liver resection for hepatocellular carcinoma in preventing early-phase local recurrence after surgery.

Shimizu A, Kubota K, Notake T, Kitagawa N, Masuo H, Yoshizawa T J Hepatobiliary Pancreat Sci. 2024; 31(8):513-527.

PMID: 38803276 PMC: 11503460. DOI: 10.1002/jhbp.12004.


Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis.

Li Y, Wei S, Fu Y, Zeng Z, Huang L, Lv J Front Oncol. 2024; 14:1372123.

PMID: 38628666 PMC: 11018934. DOI: 10.3389/fonc.2024.1372123.


Refining MRI-based criteria for portal vein invasion in hepatocellular carcinoma: improving sensitivity beyond portal vein tumor thrombosis.

Kim J, Jeong W, Kim J, Ha S, Kim K Abdom Radiol (NY). 2023; 49(2):437-446.

PMID: 37989897 DOI: 10.1007/s00261-023-04106-6.


Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges.

Wang D, Xiao M, Wan Z, Lin X, Li Q, Zheng S World J Gastrointest Surg. 2023; 15(4):544-552.

PMID: 37206072 PMC: 10190723. DOI: 10.4240/wjgs.v15.i4.544.